First pass effect

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

First-pass metabolism; Presystemic elimination

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

In order for a perorally administered pharmaceutical active ingredient to develop its effects at the site of action, it must usually enter the systemic bloodstream (bioavailability). To do so, it must pass through the intestinal wall, the liver and part of the circulation. Despite complete absorption in the intestine, the bioavailability of a drug can be reduced to a relevant extent, i.e. in the mucous membrane of the small intestine(CYP3A4), in the liver (CYP3A4 and other CYP enzymes) and in the small circulation.

Note(s)This section has been translated automatically.

The first-pass metabolism is often referred to the liver. Documented are, however, examples for active agents which are already metabolized in the intestinal mucosa to a relevant extent (e.g. Ciclosporin, Midazolam, Nifedipin and Tacrolimus).

Authors

Last updated on: 29.10.2020